₹ 943.34 Cr
2.33%
S&P BSE Healthcare TRI
INF789F01695
5000.0
1000.0
500
Kamal Gada
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
UTI Healthcare Fund - Regular Plan - Growth Option | 51.96 | 12.23 | 22.75 |
S&P BSE Healthcare TRI | 55.02 | 14.07 | 22.77 |
Equity
Debt
Others
An open-end fund which exclusively invests in the equities of the pharma & healthcare sector companies. This fund is one of the growth sector fund s aiming to invest in companies engaged in business of manufacturing and marketing of bulk drug, formulations and health care products and service.
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 12.62 |
Cipla Ltd. | 6.72 |
Ajanta Pharma Ltd. | 5.85 |
Dr. Reddy's Laboratories Ltd. | 5.26 |
Apollo Hospitals Enterprise Ltd. | 4.41 |
Aurobindo Pharma Ltd. | 3.67 |
Fortis Healthcare Ltd. | 3.49 |
Krishna Institute of Medical Sciences Ltd | 3.45 |
Eris Lifesciences Ltd. | 3.29 |
Procter & Gamble Health Ltd. | 3.26 |
Sector | Holdings (%) |
---|---|
Healthcare | 97.87 |
Others | 1.41 |
Insurance | 0.61 |
Financial | 0.13 |
Scheme Name | 5Y (%) |
---|---|
UTI Healthcare Reg Gr | 22.75 |
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 25.89 |
ABSL Pharma and Healthcare Reg Gr | 0.0 |
Tata India Pharma & Healthcare Reg Gr | 23.76 |
Nippon India Pharma Fund Gr Gr | 24.6 |
DSP Healthcare Reg Gr | 26.88 |
Mirae Asset Healthcare Reg Gr | 25.31 |
SBI HEALTHCARE Opportunities Reg Gr | 24.74 |
LIC MF Healthcare Fund Reg Gr | 19.33 |
ITI Pharma and Healthcare Fund Reg Gr | 0.0 |